Fundraising FoxBluebird Ventures — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Procyrion develops medical devices for circulatory support in heart failure treatment, supported by a team of cardiologists and medical device industry veterans.
BiotechHealthtechMedical DevicesHouston, US
Reynolds, III M. Delagado(Director)Benjamin A. Hertzog(Executive Officer, Director)Dr. Fain(Founder/Executive)Jason J Heuring(Executive Officer)Bryan E. Nearn(Vice President)
BoardLeo III E Linbeck(Director)
PartnerJeffrey Bird· solo GP
Co-investorsScientific Health DevelopmentTexas VenturesFannin Goldenrod Holdings
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.